SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-313403
Filing Date
2020-12-09
Accepted
2020-12-09 09:03:32
Documents
14
Period of Report
2020-12-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d75325d8k.htm   iXBRL 8-K 27156
2 EX-10.1 d75325dex101.htm EX-10.1 281966
6 GRAPHIC g75325g1209112403160.jpg GRAPHIC 1759
  Complete submission text file 0001193125-20-313403.txt   490203

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mgen-20201209.xsd EX-101.SCH 3090
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgen-20201209_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgen-20201209_pre.xml EX-101.PRE 10966
7 EXTRACTED XBRL INSTANCE DOCUMENT d75325d8k_htm.xml XML 3271
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 201377023
SIC: 8071 Services-Medical Laboratories